Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
2.
Invest Ophthalmol Vis Sci ; 51(10): 5105-13, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20435582

ABSTRACT

PURPOSE: To investigate the anti-inflammatory effects of guggulsterone, an antioxidant and antitumor agent, in endotoxin-induced uveitis (EIU) in rats and to elucidate the underlying molecular mechanism or mechanisms related to ocular inflammation. METHODS: EIU was induced by subcutaneous injection of lipopolysaccharide (LPS; 150 µg) into Lewis rats treated with guggulsterone (30 mg/kg body weight, intraperitoneally) or its carrier. After 24 hours the rats were killed, eyes were enucleated, and aqueous humor (AqH) was collected. Numbers of infiltrating cells and levels of matrix metalloproteinase-2 (MMP-2), nitric oxide (NO), and prostaglandin E(2) (PGE(2)) were determined in AqH by specific ELISAs. An antibody array was used to measure the expression of various inflammatory cytokines in AqH. The expression of MMP-2, iNOS, Cox-2, phospho-IκB, and phospho-NF-κB was determined immunohistochemically. Human primary nonpigment ciliary epithelial cells (HNPECs) were used to determine the in vitro efficacy of guggulsterone on the LPS-induced inflammatory response. RESULTS: Compared with control, the EIU rat eye AqH had a significantly higher number of infiltrating cells, total protein, and inflammatory markers, such as MMP-2, NO, and PGE(2), and the treatment of guggulsterone prevented EIU-induced increases. Guggulsterone also prevented the expression of MMP-2, iNOS, and Cox-2 proteins and of IκB and NF-κB in various eye tissues. Moreover, in cultured HNPECs, guggulsterone inhibited LPS-induced expression of inflammatory proteins. CONCLUSIONS: These results for the first time demonstrate that the plant sterol guggulsterone suppresses ocular inflammation in EIU, suggesting that the supplementation of guggulsterone could be a novel approach for the treatment of ocular inflammation.


Subject(s)
Antineoplastic Agents/therapeutic use , Antioxidants/therapeutic use , Commiphora , Disease Models, Animal , Lipopolysaccharides , Pregnenediones/therapeutic use , Uveitis/prevention & control , Animals , Aqueous Humor/cytology , Aqueous Humor/metabolism , Blotting, Western , Cells, Cultured , Ciliary Body/drug effects , Cytokines/metabolism , Dinoprostone/metabolism , Enzyme-Linked Immunosorbent Assay , Escherichia coli , Humans , I-kappa B Proteins/metabolism , Injections, Intraperitoneal , Male , Matrix Metalloproteinase 2/metabolism , NF-kappa B/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Rats , Rats, Inbred Lew , Uveitis/chemically induced , Uveitis/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL